FDA Approved: OXAZEPAM — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Oxazepam (generic) submitted by Actavis Pharma, Inc. (ANDA072253).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Generalized Anxiety Disorder

Drugs mentioned

• OXAZEPAM (OXAZEPAM)

Snippet

SUPPL AP for OXAZEPAM (OXAZEPAM)